NCT01954992 2024-12-31
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
Eleison Pharmaceuticals LLC.
Phase 3 Recruiting
Clinical Trials
1 trialsPhase 3 × Metastatic Pancreatic Adenocarcinoma × beta-D-glucosylisophosphoramide mustard × Clear all